141.11
前日終値:
$139.20
開ける:
$140.28
24時間の取引高:
1.27M
Relative Volume:
0.54
時価総額:
$39.85B
収益:
$7.23B
当期純損益:
$1.41B
株価収益率:
28.34
EPS:
4.979
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
+0.58%
1か月 パフォーマンス:
+7.97%
6か月 パフォーマンス:
+8.85%
1年 パフォーマンス:
+22.82%
Agilent Technologies Inc Stock (A) Company Profile
名前
Agilent Technologies Inc
セクター
電話
(408) 345-8886
住所
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
A
Agilent Technologies Inc
|
141.11 | 38.94B | 7.23B | 1.41B | 1.09B | 4.979 |
|
TMO
Thermo Fisher Scientific Inc
|
577.83 | 207.93B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
199.66 | 138.14B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
584.78 | 43.87B | 4.45B | 1.10B | 1.06B | 13.59 |
|
IQV
Iqvia Holdings Inc
|
236.05 | 35.59B | 16.63B | 1.39B | 2.12B | 8.0674 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | 開始されました | HSBC Securities | Buy |
| 2026-01-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-12-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-02 | 開始されました | Morgan Stanley | Overweight |
| 2025-10-08 | 開始されました | Rothschild & Co Redburn | Buy |
| 2025-10-08 | アップグレード | UBS | Neutral → Buy |
| 2025-02-10 | アップグレード | Barclays | Underweight → Equal Weight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-07-10 | アップグレード | Citigroup | Neutral → Buy |
| 2024-06-27 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | 再開されました | Jefferies | Hold |
| 2024-04-05 | アップグレード | Stifel | Hold → Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-12-12 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-11-17 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-31 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-05-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-24 | 繰り返されました | BofA Securities | Buy |
| 2023-05-24 | 繰り返されました | Citigroup | Neutral |
| 2023-05-24 | 繰り返されました | Credit Suisse | Outperform |
| 2023-05-24 | 繰り返されました | Evercore ISI | Outperform |
| 2023-05-24 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-05-24 | 繰り返されました | SVB Securities | Outperform |
| 2023-05-24 | 繰り返されました | Stifel | Hold |
| 2023-05-24 | 繰り返されました | TD Cowen | Outperform |
| 2023-05-24 | 繰り返されました | Wells Fargo | Overweight |
| 2023-05-11 | 開始されました | Barclays | Equal Weight |
| 2023-01-10 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-20 | 開始されました | UBS | Buy |
| 2022-07-08 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | 繰り返されました | BofA Securities | Buy |
| 2022-02-23 | 繰り返されました | Citigroup | Buy |
| 2022-02-23 | 繰り返されました | Cowen | Outperform |
| 2022-02-23 | 繰り返されました | Evercore ISI | Outperform |
| 2022-02-23 | 繰り返されました | Stifel | Hold |
| 2022-02-23 | 繰り返されました | Wells Fargo | Overweight |
| 2021-11-23 | 繰り返されました | BofA Securities | Buy |
| 2021-11-23 | 繰り返されました | Cowen | Outperform |
| 2021-11-23 | 繰り返されました | Stifel | Hold |
| 2021-03-18 | アップグレード | Citigroup | Neutral → Buy |
| 2021-02-17 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-25 | アップグレード | UBS | Neutral → Buy |
| 2020-11-17 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | 開始されました | Atlantic Equities | Neutral |
| 2020-08-19 | 繰り返されました | BofA Securities | Neutral |
| 2020-08-19 | 繰り返されました | Citigroup | Neutral |
| 2020-08-19 | 繰り返されました | Jefferies | Buy |
| 2020-08-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2020-08-19 | 繰り返されました | SVB Leerink | Outperform |
| 2020-08-19 | 繰り返されました | Stifel | Hold |
| 2020-08-19 | 繰り返されました | Wells Fargo | Overweight |
| 2020-02-24 | ダウングレード | Needham | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-11-26 | 繰り返されました | Needham | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | UBS | Buy → Neutral |
| 2019-07-16 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | ダウングレード | Barclays | Overweight → Equal Weight |
すべてを表示
Agilent Technologies Inc (A) 最新ニュース
Agilent Technologies Inc (A) Institutional Confidence - TradingKey
Agilent Technologies Inc (A): GF Score of 94 Signals Strong Outp - GuruFocus
Agilent Technologies Inc (A) Cash Flow - TradingKey
Agilent Technologies price driven lower by important resistanceForecast today27-07-2026 - Economies.com
Precision Trading with Agilent Technologies Inc. (A) Risk Zones - Stock Traders Daily
Agilent Technologies Inc (A) Balance Sheet - TradingKey
Agilent Technologies, Inc. (A) Stock Analysis: Exploring A 14.97% Upside Potential - DirectorsTalk Interviews
Agilent Technologies Inc (A) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agilent Technologies stock steadies as investors weigh recent earnings and life-science demand trend - Ad-hoc-news.de
A|Agilent Technologies Inc|Price:138.570|Chg%:-1.185 - TradingKey
Is Agilent Technologies (A) Undervalued Following Its FDA Approval For OPDIVO Companion Diagnostics? - Yahoo Finance UK
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test - Yahoo Finance
Agilent Technologies Inc (A) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Agilent Technologies Inc (A) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Agilent Technologies Inc (A) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
What to Expect From Agilent Technologies' Q3 2026 Earnings Report - inkl
A|Agilent Technologies Inc|Price:137.910|Chg%:-0.660 - TradingKey
Agilent declares Q2 2026 distribution of R$ 0.44 per unit, payable July 28 - Bitget
A Look at Agilent Technologies Inc (A) After 4.7% Gain -- GF Val - GuruFocus
Agilent Technologies Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Agilent Technologies (A) Secures EU Certification for Key Diagno - GuruFocus
Why Agilent Technologies Shares Are Rising Today - Quiver Quantitative
Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers - Moomoo
Agilent stock rises on EU approval for cancer diagnostic By Investing.com - Investing.com South Africa
Agilent stock rises on EU approval for cancer diagnostic - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test - Investing.com
Agilent receives EU approval for ovarian cancer diagnostic test By Investing.com - Investing.com South Africa
Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Yahoo Finance
Agilent Technologies Inc (A) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Agilent BDR program executes 5-for-1 stock split on ratio adjustment - Bitget
A4881169 Bond Profile — Key Metrics - TradingView
Agilent Technologies (A) Stock Forecast & Analyst Ratings - Moomoo
Agilent stock holds near report levels as earnings metrics stay in view - Ad-hoc-news.de
Agilent Technologies (NYSE:A) Gains Fresh FDA Momentum - Kalkine Media
Agilent Technologies stock trades steady as life sciences demand supports revenue outlook - Ad-hoc-news.de
Michael Buckner Joins Agilent Technologies as Chief Legal Officer - Medical Product Outsourcing
Agilent Technologies stock trades steadily as investors weigh recent earnings and life sciences dema - Ad-hoc-news.de
Agilent increases HALO X-ray Technologies stake - Airports International
HALO X-ray Technologies Ltd announced that it has received funding from Agilent Technologies, Inc., Future Planet Capital, British Business Investments Ltd., Future Planet Capital Limited - marketscreener.com
Agilent Technologies (A) Stock Analysis: Unlocking a 21% Upside Potential with Robust Market Presence - DirectorsTalk Interviews
Agilent Technologies (A) Wells Fargo 20th Annual Healthcare Conference 2025 Summary - Quartr
Agilent Increases Its Investment in HALO X-ray Technologies - Morningstar
Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now? - Sahm
Agilent Technologies (A) Q2 2025 earnings summary - Quartr
Agilent Technologies (A) Q1 2026 earnings summary - Quartr
Agilent Technologies stock trades steady as recent earnings and life-science demand underpin valuati - Ad-hoc-news.de
Agilent Technologies (A) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
Agilent Technologies (A) Proxy Filing Summary - Quartr
Agilent Technologies (A) Q4 2025 earnings summary - Quartr
Agilent Technologies stock holds support as results stay in focus - Ad-hoc-news.de
Agilent 1260 Infinity II LC by Agilent Technologies Inc.mid-range workhorse for routine labs - Ad-hoc-news.de
Agilent Technologies Inc (A) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):